Item description for Retinal Vascular Disease by A.M. Joussen...
Vascular diseases of the retina are a major cause of blindness among all age groups. Edited and written by internationally well-known experts, this state-of-the-art comprehensive overview of basic and clinical science will enhance the understanding of retinal vascular disease and help in the evaluation of current and future treatment approaches for the clinician. The well-structured and highly illustrated text is divided into the following three main sections: Pathogenesis of retinal vascular disease General concepts in the diagnosis and treatment of retinal vascular disease Pathology, clinical course and treatment of retinal vascular disease Reader-friendly through: Step-by-step explanation of all treatment procedures Richly illustrated by clinical image series including illustrated single case follow-up
This unique textbook-atlas also includes topics which are not currently found in other retinal disease textbooks, such as case reports and clinical follow-ups. General ophthalmologists, retina specialists as well as ophthalmologists in training will find this book highly stimulating and useful for their daily practice.
Promise Angels is dedicated to bringing you great books at great prices. Whether you read for entertainment, to learn, or for literacy - you will find what you want at promiseangels.com!
Est. Packaging Dimensions: Length: 10.79" Width: 7.8" Height: 1.57" Weight: 5.29 lbs.
Release Date Oct 23, 2007
ISBN 3540295410 ISBN13 9783540295419
Reviews - What do customers think about Retinal Vascular Disease?
Angiogenesis is cool Feb 25, 2008
Antonia Joussen, who has shot through the ranks of German Academia thanks to an excellent foundation in research -and that was apparent as I briefly met her at ARVO in 95- has joined teams with an elaborate group of scientists and clinicians from both sides of the atlantic. There is some redundancy but here is tons of insight to be gained from the somewhat different approaches that two very advanced clinical systems have developed. As someone who trained on both sides of the Atlantic I find this very interesting and educational. Michael Larsen's description of a different clincal system for diabetic retinopathy may sound like heresy for ETDRS trained americans, but may make more sense in the long run. The recent "streamlining" of ETDRS in the US ay be an indication of this. Anyhow, with about half of the book dedicated equally to basic science and clinic I find that this is a must read for anyone treating retinal disease today and does not want to have to believe speakers on meetings that are supported by "an unrestricted educational grant from .....". My only hope is that the team will be ready for a complete update in 3-4 years, as this is a field that is changing so fast...Please keep up the spirit for a second round.
Lars Freisberg MD -a more formal review is in the making